Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors-Reference-Cited by-同舟云学术

Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Published:2010-06-09 Issue:13 Volume:53 Page:4906-4916
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Qin Bingjie¹,Jiang Xingkai¹,Lu Hong²,Tian Xingtao¹,Barbault Florent³,Huang Li⁴,Qian Keduo⁵,Chen Chin-Ho⁴,Huang Rong⁵,Jiang Shibo²,Lee Kuo-Hsiung⁵,Xie Lan¹

Affiliation:

1. Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, China

2. Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York 10065

3. ITODYS, Université Paris Diderot—CNRS UMR 7086, 15 rue Jean de Baïf, 75205 Paris, France

4. Duke University Medical Center, Box 2926, Surgical Oncology Research Facility, Durham, North Carolina 27710

5. Natural Products Research Laboratories, University of North Carolina, Chapel Hill, North Carolina 27599

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1002952

Reference43 articles.

1. Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase

2. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections

3. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1

4. In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)

5. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of Quantitative Structure-Activity Relationship (QSAR) of Diarylaniline Analogues as in Vitro Anti-HIV-1 Agents in Pharmaceutical Interest;CHEM METHODOL;2023

2. Molecular mechanism study of the structural regulation of the N-terminal domain binding antibody on the receptor binding domain of SARS-CoV-2;Physical Chemistry Chemical Physics;2023

3. Diarylpyrimidines and related analogs as antiviral agents;Privileged Scaffolds in Drug Discovery;2023

4. Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors;Journal of Medicinal Chemistry;2022-02-17

5. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel;European Journal of Medicinal Chemistry;2021-12